Novavax Advances Development of Novel COVID-19 Vaccine
Go back to Novavax Advances Development of Novel COVID-19 Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 7.93 -0.14 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.07 | 52 Week High | $9.23 | |||
| Open | $7.97 | 52 Week Low | $1.16 | |||
| Day High | $8.08 | P/E | N/A | |||
| Day Low | $7.84 | EPS | $-0.30 | |||
| Volume | 2,010,404 | |||||
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 7.93 -0.14 (1.73%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.07 | 52 Week High | $9.23 | |||
| Open | $7.97 | 52 Week Low | $1.16 | |||
| Day High | $8.08 | P/E | N/A | |||
| Day Low | $7.84 | EPS | $-0.30 | |||
| Volume | 2,010,404 | |||||

